Matthew DEATER to Fanconi Anemia Complementation Group D2 Protein
This is a "connection" page, showing publications Matthew DEATER has written about Fanconi Anemia Complementation Group D2 Protein.
Connection Strength
0.327
-
Combination therapy with atorvastatin and celecoxib delays tumor formation in a Fanconi anemia mouse model. Pediatr Blood Cancer. 2019 01; 66(1):e27460.
Score: 0.154
-
Evaluation of resveratrol and N-acetylcysteine for cancer chemoprevention in a Fanconi anemia murine model. Pediatr Blood Cancer. 2014 Apr; 61(4):740-2.
Score: 0.109
-
Metformin improves defective hematopoiesis and delays tumor formation in Fanconi anemia mice. Blood. 2016 12 15; 128(24):2774-2784.
Score: 0.034
-
Oxymetholone therapy of fanconi anemia suppresses osteopontin transcription and induces hematopoietic stem cell cycling. Stem Cell Reports. 2015 Jan 13; 4(1):90-102.
Score: 0.030